Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Parse Score
Sources
investors.freenome.com shapes more of what AI says about Freenome than any other source, at 22% of its citations.
analyticsvidhya.com · asianhhm.com · freenome.com · healthcare-marketing.agency
Excerpts where Freenome appeared in the AI's answer
Freenome's SimpleScreen CRC is notable because it crossed an important regulatory threshold: the FDA approved it in July 2026 for average-risk adults 45+ as a blood-based colorectal-cancer screening test.
Freenome: Uses machine learning to parse multi-omics data from routine blood draws
Excerpts where Freenome appeared in the AI's answer
Freenome : Develops blood-based tests (liquid biopsies) that use multi-omics (cfDNA, proteins) for early cancer detection.
Freenome — combines blood biomarkers and AI with the long-term goal of enabling earlier intervention.
